Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2009
11/11/2009EP2116535A1 Glucokinase-activating substance
11/11/2009EP2116533A1 Glucokinase activator
11/11/2009EP1874745B1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
11/11/2009EP1477186B1 Antipruritics
11/11/2009CN101578275A Anilinopiperazine derivatives and methods of use thereof
11/11/2009CN101578269A N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g.
11/11/2009CN101578261A Heteroaryl-substituted serine amides
11/11/2009CN100558717C Novel medicine
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/10/2009US7615569 Inhibitors of ion channels
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/05/2009WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009WO2009085226A3 Inhibitors of cdc2-like kinases (clks) and methods of use thereof
11/05/2009WO2008106080A9 Synthesis of desacetoxytubulysin h and analogs thereof
11/05/2009US20090275625 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-phenyl-thiazolidin-4-one; {2-[4-(2-([Z]-isopropylimino)-4-oxo-3-phenyl-thiazolidin-5-[Z]-ylidenemethyl)-phenoxy]-ethoxy}-acetic acid; immunosuppressant agents; multiple sclerosis, psoriasis
11/05/2009US20090275621 peroxisome proliferator-activated receptors (PPAR) modulators such as 5-(4-{2-[5-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-ethoxy}-phenyl)-3H-[1,3,4]oxadiazol-2-one, used for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization
11/05/2009US20090275588 Novel sulfonamide compounds
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/04/2009EP2113031A1 Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1473286B1 Process for producing biaryl compound
11/04/2009EP1444739B1 Light emitting device and compounds for use therein
11/04/2009EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
10/2009
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009WO2009129661A1 A process for preparing 5-hydroxymethylthiazole
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270460 Fxr agonists
10/29/2009US20090270456 Novel chemical compounds
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270363 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
10/29/2009CA2722041A1 Novel five-membered ring compound
10/28/2009CN101568527A 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/28/2009CN101565408A Receptor signal transduction positive modulator, preparation method and purpose thereof
10/27/2009US7608721 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009WO2009104200A8 A method for preparation of thiazolidinedione derivatives
10/22/2009US20090264660 Process for alkyl aryl sulfide derivatives and new sulfide compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264405 Cetp Inhibitors
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009CN101563395A Polyimide, diamine compound and method for producing the same
10/21/2009CN101560195A Preparation method of 4-methyl-5-(2-hydroxyethyl)-thiazole
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/21/2009CN100551918C Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
10/21/2009CN100551917C Method for synthesizing rubber accelerator DZ
10/21/2009CN100551907C Compound in category of aryl methylamino dithio formic ether, preparation method and application
10/21/2009CN100551532C Method for preparing bisphenol catalysts and bisphenols
10/20/2009US7605174 Indane derivatives as modulators of ion channels
10/20/2009US7605172 Plasminogen activator inhibitor-1 (PAI-1) modulators; 3-phenyl-2-{[6-(2-phenyl-1,3-thiazol-4-yl)-2-naphthyl]oxy}propanoic acid; thrombosis; cardiovascular disease
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2492854C Sustained-release tablet composition of pramipexole
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2408135C Method for producing 2-chloro-5-chloromethyl-1,3-thiazole
10/15/2009WO2009056811A3 Tetrahydrobenzothiazole derivatives with dopamine receptor activity
10/15/2009WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests
10/15/2009US20090258915 Ribonucleotide reductase inhibitors and methods of use
10/15/2009US20090258914 Inhibitor of Anti-Apoptotic Proteins
10/15/2009US20090258912 N-(1-Alkyl-2-Phenylethyl)-Carboxamide Derivatives and Use Thereof as Fungicides
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/14/2009EP2108644A1 N-(methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
10/14/2009EP1701722B1 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt
10/14/2009EP1572248B1 Solid-phase fluorination of benzothiazoles
10/14/2009CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548995C Method for preparing compound of thiazole formaldehyde class
10/14/2009CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/13/2009US7601841 Quinolinyl and benzothiazolyl modulators
10/13/2009US7601746 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid
10/13/2009US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 337